Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
Not Applicable
Completed
- Conditions
- Percutaneous Coronary Artery InterventionCoronary Artery Bypass GraftAcute Coronary Syndrome
- Interventions
- Drug: cipher prescription 2Drug: cipher prescription 1
- Registration Number
- NCT00965471
- Lead Sponsor
- Guangzhou University of Chinese Medicine
- Brief Summary
The purpose of this study is to built the standard of Chinese Traditional Medicine test for Post percutaneous coronary artery intervention and coronary artery bypass graft,also for acute coronary syndrome,according to the multi-site、random large sample test.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 940
Inclusion Criteria
- age40~75
- angina or CAD patient
- deficiency of heart-QI and blockage of phlegm and blood stasis in chinese medicine
- 1 week after operation,or 1week after drainage tube extraction for CABG
- sign a informed consent
Exclusion Criteria
- severe cardia failure
- severe renal inadequacy
- complicating with malignant tumor,reactive alimentary tract hemorrhage and haematological systemic disorder etc.
- psychotic
- pregnant,lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control group cipher prescription 2 - managed group cipher prescription 1 -
- Primary Outcome Measures
Name Time Method dead 180±3days
- Secondary Outcome Measures
Name Time Method cardiovascular event 180±3days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of cipher prescriptions in post-revascularization coronary artery disease?
How do cipher prescription 1 and 2 compare to standard antiplatelet therapy in preventing restenosis after PCI or CABG?
Are there specific biomarkers that predict response to Chinese Traditional Medicine in acute coronary syndrome patients post-revascularization?
What adverse events are associated with cipher prescriptions in long-term post-revascularization treatment of CAD?
What combination therapies with cipher prescriptions show promise in managing post-revascularization CAD compared to monotherapy?